Methylenedioxyallylamphetamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

Methylenedioxyallylamphetamine (MDAL or 3,4-methylenedioxy-N-allylamphetamine) is a lesser-known drug.[1][2][2] It is the N-allyl derivative of 3,4-methylenedioxyamphetamine (MDA).[1][2]

Other namesMDAL; 3,4-Methylenedioxy-N-allylamphetamine
ATC code
  • None
Quick facts Clinical data, Other names ...
MDAL
Clinical data
Other namesMDAL; 3,4-Methylenedioxy-N-allylamphetamine
Routes of
administration
Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • N-[1-(2H-1,3-benzodioxol-5-yl)propan-2-yl]prop-2-en-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H17NO2
Molar mass219.284 g·mol−1
3D model (JSmol)
  • C1=C2C(=CC=C1CC(C)NCC=C)OCO2
  • InChI=1S/C13H17NO2/c1-3-6-14-10(2)7-11-4-5-12-13(8-11)16-9-15-12/h3-5,8,10,14H,1,6-7,9H2,2H3 ☒N
  • Key:BMKCDDFQEGYEJC-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)
Close

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDAL's minimum dose as 180 mg orally and its duration as unknown.[1][2] MDAL produces few to no effects on its own, but may enhance the effects of psychedelic drugs like LSD.[1]

Chemistry

Synthesis

The chemical synthesis of MDAL has been described.[1]

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[3]

See also

References

Related Articles

Wikiwand AI